Events Partner Content Advancing the Next Generation of Microbiome-Based Therapeuti... Join the Microbiome Movement in Asia
Partner Content Partner Content 4 Reasons Why Asia is the Next Hub of Microbiome Innovation Microbiome R&D in Asia-Pacific
News Promethera looks to Asia with €10m investment Belgium-based liver disease specialists Promethera Biosciences have received a leg-up for the Asian market in the form of a €10 million investment from Japanese business conglomerate ITOCHU Corp
News FDA finally okays Novavax's COVID-19 jab, with restrictions The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
